Neutrophil-to-lymphocyte ratio in combination with PD-L1 or lactate dehydrogenase as biomarkers for high PD-L1 non-small cell lung cancer treated with first-line pembrolizumab

Giuseppe Luigi Banna, Diego Signorelli, Giulio Metro, Domenico Galetta, Alessandro De Toma, Ornella Cantale, Marco Banini, Alex Friedlaender, Pamela Pizzutillo, Marina Chiara Garassino, Alfredo Addeo